Erythropoietic Stimulating Agent (ESA) dosage determination
An Erythropoietic Stimulating Agent (ESA) dosing system/method determines patient-specific ESA therapies for patients affected by insufficient hemoglobin production that may benefit from ESA treatment. The ESA dosing system includes a model that represents a process by which red blood cells are prod...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MCCARTHY, JAMES T DINGLI, DAVID GALLAHER, EDWARD G ROGERS, JAMES L HOCUM, CRAIG L STEENSMA, DAVID P |
| description | An Erythropoietic Stimulating Agent (ESA) dosing system/method determines patient-specific ESA therapies for patients affected by insufficient hemoglobin production that may benefit from ESA treatment. The ESA dosing system includes a model that represents a process by which red blood cells are produced in humans. The model may include one or more parameters, the values of which are patient-specific. The model takes into account patient-specific historical hemoglobin (Hgb) data and corresponding historical ESA dosage data to estimate the patient-specific values of the model parameters, and determines a target therapeutic dose of the ESA that may maintain the patient's Hgb within a target range. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2011203456BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2011203456BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2011203456BB23</originalsourceid><addsrcrecordid>eNrjZLB2LaosySjKL8jPTC3JTFYILsnMLc1JLMnMS1dwTE_NK1HQcA121FRIyS9OTE9VSEktSS3KzcwDKsjP42FgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGhkYGxiamZk5ORsZEKgMAs-gwdg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Erythropoietic Stimulating Agent (ESA) dosage determination</title><source>esp@cenet</source><creator>MCCARTHY, JAMES T ; DINGLI, DAVID ; GALLAHER, EDWARD G ; ROGERS, JAMES L ; HOCUM, CRAIG L ; STEENSMA, DAVID P</creator><creatorcontrib>MCCARTHY, JAMES T ; DINGLI, DAVID ; GALLAHER, EDWARD G ; ROGERS, JAMES L ; HOCUM, CRAIG L ; STEENSMA, DAVID P</creatorcontrib><description>An Erythropoietic Stimulating Agent (ESA) dosing system/method determines patient-specific ESA therapies for patients affected by insufficient hemoglobin production that may benefit from ESA treatment. The ESA dosing system includes a model that represents a process by which red blood cells are produced in humans. The model may include one or more parameters, the values of which are patient-specific. The model takes into account patient-specific historical hemoglobin (Hgb) data and corresponding historical ESA dosage data to estimate the patient-specific values of the model parameters, and determines a target therapeutic dose of the ESA that may maintain the patient's Hgb within a target range.</description><language>eng</language><subject>CALCULATING ; COMPUTING ; COUNTING ; ELECTRIC DIGITAL DATA PROCESSING ; HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA ; INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS ; PHYSICS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140731&DB=EPODOC&CC=AU&NR=2011203456B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140731&DB=EPODOC&CC=AU&NR=2011203456B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MCCARTHY, JAMES T</creatorcontrib><creatorcontrib>DINGLI, DAVID</creatorcontrib><creatorcontrib>GALLAHER, EDWARD G</creatorcontrib><creatorcontrib>ROGERS, JAMES L</creatorcontrib><creatorcontrib>HOCUM, CRAIG L</creatorcontrib><creatorcontrib>STEENSMA, DAVID P</creatorcontrib><title>Erythropoietic Stimulating Agent (ESA) dosage determination</title><description>An Erythropoietic Stimulating Agent (ESA) dosing system/method determines patient-specific ESA therapies for patients affected by insufficient hemoglobin production that may benefit from ESA treatment. The ESA dosing system includes a model that represents a process by which red blood cells are produced in humans. The model may include one or more parameters, the values of which are patient-specific. The model takes into account patient-specific historical hemoglobin (Hgb) data and corresponding historical ESA dosage data to estimate the patient-specific values of the model parameters, and determines a target therapeutic dose of the ESA that may maintain the patient's Hgb within a target range.</description><subject>CALCULATING</subject><subject>COMPUTING</subject><subject>COUNTING</subject><subject>ELECTRIC DIGITAL DATA PROCESSING</subject><subject>HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA</subject><subject>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</subject><subject>PHYSICS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB2LaosySjKL8jPTC3JTFYILsnMLc1JLMnMS1dwTE_NK1HQcA121FRIyS9OTE9VSEktSS3KzcwDKsjP42FgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGhkYGxiamZk5ORsZEKgMAs-gwdg</recordid><startdate>20140731</startdate><enddate>20140731</enddate><creator>MCCARTHY, JAMES T</creator><creator>DINGLI, DAVID</creator><creator>GALLAHER, EDWARD G</creator><creator>ROGERS, JAMES L</creator><creator>HOCUM, CRAIG L</creator><creator>STEENSMA, DAVID P</creator><scope>EVB</scope></search><sort><creationdate>20140731</creationdate><title>Erythropoietic Stimulating Agent (ESA) dosage determination</title><author>MCCARTHY, JAMES T ; DINGLI, DAVID ; GALLAHER, EDWARD G ; ROGERS, JAMES L ; HOCUM, CRAIG L ; STEENSMA, DAVID P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2011203456BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>CALCULATING</topic><topic>COMPUTING</topic><topic>COUNTING</topic><topic>ELECTRIC DIGITAL DATA PROCESSING</topic><topic>HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA</topic><topic>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</topic><topic>PHYSICS</topic><toplevel>online_resources</toplevel><creatorcontrib>MCCARTHY, JAMES T</creatorcontrib><creatorcontrib>DINGLI, DAVID</creatorcontrib><creatorcontrib>GALLAHER, EDWARD G</creatorcontrib><creatorcontrib>ROGERS, JAMES L</creatorcontrib><creatorcontrib>HOCUM, CRAIG L</creatorcontrib><creatorcontrib>STEENSMA, DAVID P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MCCARTHY, JAMES T</au><au>DINGLI, DAVID</au><au>GALLAHER, EDWARD G</au><au>ROGERS, JAMES L</au><au>HOCUM, CRAIG L</au><au>STEENSMA, DAVID P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Erythropoietic Stimulating Agent (ESA) dosage determination</title><date>2014-07-31</date><risdate>2014</risdate><abstract>An Erythropoietic Stimulating Agent (ESA) dosing system/method determines patient-specific ESA therapies for patients affected by insufficient hemoglobin production that may benefit from ESA treatment. The ESA dosing system includes a model that represents a process by which red blood cells are produced in humans. The model may include one or more parameters, the values of which are patient-specific. The model takes into account patient-specific historical hemoglobin (Hgb) data and corresponding historical ESA dosage data to estimate the patient-specific values of the model parameters, and determines a target therapeutic dose of the ESA that may maintain the patient's Hgb within a target range.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2011203456BB2 |
| source | esp@cenet |
| subjects | CALCULATING COMPUTING COUNTING ELECTRIC DIGITAL DATA PROCESSING HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS PHYSICS |
| title | Erythropoietic Stimulating Agent (ESA) dosage determination |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T13%3A22%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MCCARTHY,%20JAMES%20T&rft.date=2014-07-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2011203456BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |